EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therapeutic avenue

Lavanya Choppavarapu, Kun Fang, Tianxiang Liu, Aigbe G Ohihoin, Victor X Jin

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Lavanya Choppavarapu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Divison of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; MCW Cancer Center, Medical College of Wisco…. Hauptthemen laut MEDLINE: Breast Neoplasms, Chromatin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, NIH National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limitations of Hi-C (high-throughput chromosome conformation capture) profiling in in vitro cell culture include failing to recapitulate disease-specific physiological properties and lacking a clinically relevant disease microenvironment. In this study, we conduct Hi-C profiling in a pilot cohort of 12 breast tissues comprising two normal tissues, five ER+ breast primary tumors, and five tamoxifen-treated recurrent tumors. We demonstrate 3D chromatin-regulated breast tumor heterogeneity and identify a looping-mediated target gene, CA2, which might play a role in driving tamoxifen resistance. The inhibition of CA2 impedes tumor growth both in vitro and in vivo and reverses chromatin looping. The disruption of CA2 looping reduces tamoxifen-resistant cancer cell proliferation, decreases CA2 mRNA and protein expression, and weakens the looping interaction. Our study thus provides mechanistic and functional insights into the role of 3D chromatin architecture in regulating breast tumor heterogeneity and informs a new looping-mediated therapeutic avenue for treating breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsChromatinHumansFemaleTamoxifenAnimalsCell Line, TumorDrug Resistance, NeoplasmCell ProliferationMiceGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

3D chromatin architectureCP: CancerHi-C tissuesbreast tumor heterogeneitylooping-mediated therapeutic avenue

Substanzen

ChromatinTamoxifen

Autor:innen und Institutionen

  • Divison of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Mellowes Center for Genomic Sciences a…
  • Cell and Developmental Biology PhD program, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • NIH National Institute of General Medical Sciences

Zitieren

APA

Choppavarapu, L., Fang, K., Liu, T., Ohihoin, A. G., & Jin, V. X. (2025). Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therapeutic avenue. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115450

Vancouver

Choppavarapu L, Fang K, Liu T, Ohihoin AG, Jin VX. Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therapeutic avenue. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115450

BibTeX
@article{Choppavarapu2025,
  author = {Choppavarapu, Lavanya and Fang, Kun and Liu, Tianxiang and Ohihoin, Aigbe G and Jin, Victor X},
  title = {Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therapeutic avenue},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115450}
}
Kostenlos starten →